Journal article
T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice
F Wiede, BJ Shields, SH Chew, K Kyparissoudis, C Van Vliet, S Galic, ML Tremblay, SM Russell, DI Godfrey, T Tiganis
Journal of Clinical Investigation | AMER SOC CLINICAL INVESTIGATION INC | Published : 2011
DOI: 10.1172/JCI59492
Abstract
Many autoimmune diseases exhibit familial aggregation, indicating that they have genetic determinants. Single nucleotide polymorphisms in PTPN2, which encodes T cell protein tyrosine phosphatase (TCPTP), have been linked with the development of several autoimmune diseases, including type 1 diabetes and Crohn's disease. In this study, we have identified TCPTP as a key negative regulator of TCR signaling, which might explain the association of PTPN2 SNPs with autoimmune disease. We found that TCPTP dephosphorylates and inactivates Src family kinases to regulate T cell responses. Using T cell-specific TCPTP-deficient mice, we established that TCPTP attenuates T cell activation and proliferation..
View full abstractGrants
Funding Acknowledgements
We thank A. Strasser, W. Langdon, F. Carbone, W. Heath, and S. Turner for helpful discussions. This work was supported by the NHMRC of Australia (to T. Tiganis, D.I. Godfrey, and S.M. Russell); S.M. Russell is an Australian Research Council Future Fellow, and T. Tiganis and D.I. Godfrey are NHMRC Principal Research Fellows.